In the BM in particular, but in blood and lymph nodes an increase in the CD4/CD8 ratio has been associated with greater risk of BM involvement as well as worse clinical patient outcomes in follicular lymphoma [30]. This evidence concerns the gene CD4 and follicular lymphoma.